Citro, Antonio <br/><br/>
CXCR1/2 inhibition enhances pancreatic islet survival after transplantation.  [electronic resource] 

 -  The Journal of clinical investigation  Oct 2012 
 - 3647-51 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI63089  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Blood Glucose--analysis<br/>Cell Survival--drug effects<br/>Chemokine CXCL1--biosynthesis<br/>Diabetes Mellitus, Experimental--blood<br/>Diabetes Mellitus, Type 1--immunology<br/>Drug Evaluation, Preclinical<br/>Female<br/>Graft Rejection--prevention & control<br/>Graft Survival--drug effects<br/>Humans<br/>Interleukin-8--physiology<br/>Islets of Langerhans--immunology<br/>Islets of Langerhans Transplantation--immunology<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Middle Aged<br/>Natural Killer T-Cells--immunology<br/>Neutrophils--immunology<br/>Pilot Projects<br/>Receptors, Interleukin-8A--antagonists & inhibitors<br/>Receptors, Interleukin-8B--antagonists & inhibitors<br/>Sulfonamides--pharmacology<br/>Treatment Outcome